Has Arbutus Biopharma (ABUS) Outpaced Other Medical Stocks This Year? [Yahoo! Finance]
Arbutus Biopharma Corporation (ABUS)
Last arbutus biopharma corporation earnings: 11/6 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.arbutusbio.com/node/5806
Company Research
Source: Yahoo! Finance
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Arbutus Biopharma (ABUS) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question. Arbutus Biopharma is a member of our Medical group, which includes 1015 different companies and currently sits at #6 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group. The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Arbutus Biopharma is currently sporting a Zacks Rank of #2 (Buy). The Zacks Consensus Estimate fo
Show less
Read more
Impact Snapshot
Event Time:
ABUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABUS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABUS alerts
High impacting Arbutus Biopharma Corporation news events
Weekly update
A roundup of the hottest topics
ABUS
News
- Arbutus Biopharma Co. (NASDAQ: ABUS) had its price target raised by analysts at Jefferies Financial Group Inc. from $5.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
- Arbutus to Participate in Two Upcoming Investor Conferences [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Arbutus to Participate in Two Upcoming Investor ConferencesGlobeNewswire
- Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]Yahoo! Finance
- Arbutus Biopharma Co. (NASDAQ: ABUS) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
ABUS
Earnings
- 8/1/24 - Miss
ABUS
Sec Filings
- 8/16/24 - Form 4
- 8/8/24 - Form S-8
- 8/8/24 - Form 10-Q
- ABUS's page on the SEC website